GlassScriptPhysician profile
Kenneth L Rexinger
NPI 1003809963
$3,465.98
in general payments reported to CMS, 2019-2025
30 companies · $858 in 2025
The $858 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $65.88 · 2021: $63.71 · 2022: $483 · 2023: $470 · 2024: $973 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,300.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $554.53 | 2019-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $536.52 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $362.92 | 2019-2024 | Mounjaro, Zepbound, Emgality |
| Abbvie INC. | $312.77 | 2019-2025 | |
| Pfizer INC. | $232.10 | 2019-2025 | |
| Amgen INC. | $195.99 | 2019-2025 | Repatha, Otezla, Repatha |
| Lucid Diagnostics INC. | $135.28 | 2025 | |
| Janssen Pharmaceuticals, INC | $123.16 | 2019-2023 | Xarelto |
| Edwards Lifesciences Corporation | $115.04 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.53 | 2024 | Xifaxan |
| Glaxosmithkline, LLC. | $91.91 | 2022-2025 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $86.45 | 2022-2024 | |
| Astellas Pharma US INC | $66.84 | 2022-2024 | Veozah |
| Merck Sharp & Dohme LLC | $60.38 | 2019-2025 | Capvaxive, Gardasil 9 |
| Corcept Therapeutics | $58.97 | 2025 | Korlym |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53.60 | 2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $48.06 | 2025 | Cologuard Collection Kit |
| Bausch Health US, LLC | $39.72 | 2022-2024 | Aplenzin |
| Ethicon INC. | $32.94 | 2021 | |
| Inari Medical, INC. | $32.85 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Takeda Pharmaceuticals U.S.A., INC. | $26.97 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.82 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.36 | 2022 | |
| Sanofi Pasteur INC. | $25.00 | 2019 | |
| Dexcom, INC. | $25.00 | 2024 | Dexcom G6 Transmitter |
| Allergan, INC. | $18.11 | 2020 | |
| Impel Pharmaceuticals INC. | $18.09 | 2022 | |
| Genentech USA, INC. | $17.51 | 2020 | |
| Jazz Pharmaceuticals INC. | $16.63 | 2022 | |
| Boston Scientific Corporation | $12.93 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Rexinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.